Found 4 matching trials
Efficacy and Safety of 5-day Dosing of ON 01910.Na in Intermediate-1,-2, or High Risk Myelodysplastic Syndrome (MDS)
PHASE1For MDS patients who have not responded to or have progressed after an init...
Location
Memorial Sloan-Kettering Cancer Center
Safety of ON 01910.Na as a 3-day Infusion in Patients With Advanced Cancer
PHASE1The primary objective of this study is to determine the largest dose of ON ...
Location
Mount Sinai School of Medicine
Safety of 24-Hour Infusion of ON 01910.Na in Patients With Advanced Cancer
PHASE1The primary purpose of this study is to determine the highest dose of ON 01...
Location
Albert Einstein Cancer Center
Phase I Study of ON 01910.Na in Refractory Leukemia or Myelodysplastic Syndrome (MDS)
PHASE1This is an open-label, Phase I study to determine the highest amount of the...
Location
Mount Sinai Medical Center